These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19127489)

  • 21. Brain insulin resistance may exacerbate Alzheimer's progression. Researchers call it "Type III" diabetes.
    Duke Med Health News; 2012 Sep; 18(9):4-5. PubMed ID: 23029691
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of hyper- and hypoglycaemia on cognition and development of dementia for patients with diabetes mellitus Type 2].
    Wodschow HZ; Jensen NJ; Desirée Nilsson MS; Rungby J
    Ugeskr Laeger; 2018 Dec; 180(51):. PubMed ID: 30618361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic disorder (diabetes mellitus, hypoglycemia, hyperglycemia, insulin resistance)].
    Fukushima T; Sasaki H
    Nihon Rinsho; 2004 Jan; 62 Suppl():379-83. PubMed ID: 15011390
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts.
    Pantoni L; Poggesi A; Inzitari D
    Cerebrovasc Dis; 2009; 27 Suppl 1():191-6. PubMed ID: 19342851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcortical ischemic cerebrovascular dementia.
    Menon U; Kelley RE
    Int Rev Neurobiol; 2009; 84():21-33. PubMed ID: 19501711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired insulin signaling and mechanisms of memory loss.
    Bloemer J; Bhattacharya S; Amin R; Suppiramaniam V
    Prog Mol Biol Transl Sci; 2014; 121():413-49. PubMed ID: 24373245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes, hyperglycemia, and the cardiac surgery patient: introduction.
    Furnary AP
    Semin Thorac Cardiovasc Surg; 2006; 18(4):278-80. PubMed ID: 17395022
    [No Abstract]   [Full Text] [Related]  

  • 29. Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia.
    Waddell M; Flanders SJ; Golas A; Zhang Q; Juneja R
    Postgrad Med; 2009 May; 121(3):61-6. PubMed ID: 19491541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline.
    Gaspar JM; Baptista FI; Macedo MP; Ambrósio AF
    ACS Chem Neurosci; 2016 Feb; 7(2):131-42. PubMed ID: 26667832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes and risk of cognitive impairment and dementia.
    Whitmer RA
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):373-80. PubMed ID: 17764626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2009 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions.
    Nieuwenhuis-Mark RE
    Res Dev Disabil; 2009; 30(5):827-38. PubMed ID: 19269132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes, cognitive function, and the blood-brain barrier.
    Huber JD
    Curr Pharm Des; 2008; 14(16):1594-600. PubMed ID: 18673200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression and dementia.
    Korczyn AD; Halperin I
    J Neurol Sci; 2009 Aug; 283(1-2):139-42. PubMed ID: 19345960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study.
    Gavrila D; Antúnez C; Tormo MJ; Carles R; García Santos JM; Parrilla G; Fortuna L; Jiménez J; Salmerón D; Navarro C
    Acta Neurol Scand; 2009 Nov; 120(5):300-7. PubMed ID: 19832772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.